Gómez-Acebo & Pombo (Lisboa)

Mário Marques Mendes

Gómez-Acebo & Pombo (Lisboa)
Lawyer (Partner)

Mário Marques Mendes is a partner at Gómez-Acebo & Pombo, leading the EU/Competition group of the firm’s Lisbon office. He was formerly senior partner at the boutique firm Marques Mendes & Associados, which merged into Gómez-Acebo & Pombo in early 2015. He has a lifetime experience in EU and Portuguese competition laws, notably in restrictive practices, dominance, merger control and State aid matters, having represented national and international clients in cases conducted before the European Commission and the Portuguese Competition Authority and having handled important litigation before national and EU courts. He is a frequent speaker at conferences and seminars, having written extensively on various subjects of EU law, notably competition/antitrust, merger control, State aid and State intervention, as well as of international trade law. Following his graduation in the Lisbon University Law School, Mário Marques Mendes received a Diploma of High European Studies from the College of Europe, Bruges (Belgium), and, as a Fulbright Scholar, an LL.M. from the University of Michigan Law School, Ann Arbor (USA). He was a founding member and first Chairman of the Board of the Portuguese Association of Competition Lawyers (“CAPDC”), having meanwhile served as Chairman of the Advisory Council of which he is currently a member.

Linked authors

Gómez-Acebo & Pombo (Barcelona)
Gómez-Acebo & Pombo (Brussels)


2226 Review

Mário Marques Mendes, Pablo Ibáñez Colomo, Luc Gyselen, Avantika Chowdhury, Mario Siragusa, Alice Setari, Iñigo Igartua Arregui, Miguel Troncoso Ferrer, Nathalie Pétrignet, Vincent Lorieul The VBER and Vertical Guidelines: Revision or Reform? Reflection on critical issues


While the European Commission is exploring a possible revision of the VBER and of the Vertical Guidelines and assessing the various policy options proposed, this volume aims to reflect on some of the relevant issues and subjects in the VBER, some more controversial than others, but all having (...)

Send a message